MAPK11 Antikörper (AA 38-277)

Produktnummer ABIN2320726

Produktdetails anti-MAPK11 Antikörper

Target: MAPK11 (Mitogen-Activated Protein Kinase 11 (MAPK11))

Bindungsspezifität: AA 38-277

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MAPK11 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunochromatography (IC)

Sequenz: MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEF-VCSAYDARLR QKV AVKKLSRPFQ SLIHARRTYR ELRLLKHLKH ENVIGLLDVF TPATSIEDFS EVYLVTTLMG ADLNNIVKCQ ALSDEHVQFL VYQLLRGLKY IHSAGIIHRD LKPSNVAVNE DCELRILDFG LARQADEEMT GYVATRWYRA PEIMLNWMHY NQTVDIWSVG CIMAELLQGK ALFPGSDYID QLKRIMEVVG TPSPEVLAKI SSEHARTYIQ SLPPMPQKDL SSIFRGA

Kreuzreaktivität: Human

Kreuzreaktivität (Details): Calculated cross reactivity: Hu

Produktmerkmale: Mitogen Activated Protein Kinase 11 (MAPK11, P38B, P38Beta2, PRKM11, SAPK2, SAPK2B, P38-2, P38Beta)

Aufreinigung: Purified by immunoaffinity chromatography.

Immunogen: MAPK11 (Val38~Ala277), MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEF- VCS AYDARLRQKV AVKKLSRPFQ SLIHARRTYR ELRLLKHLKH ENVIGLLDVF TPATSIEDFS EVYLVTTLMG ADLNNIVKCQ ALSDEHVQFL VYQLLRGLKY IHSAGIIHRD LKPSNVAVNE DCELRILDFG LARQADEEMT GYVATRWYRA PEIMLNWMHY NQTVDIWSVG CIMAELLQGK ALFPGSDYID QLKRIMEVVG TPSPEVLAKI SSEHARTYIQ SLPPMPQKDL SSIFRGA

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working conditions should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Supplied as a liquid in PBS, pH 7.2, 0.05 % sodium azide, 50 % glycerol.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: -20°C

Details zu MAPK11

Target: MAPK11 (Mitogen-Activated Protein Kinase 11 (MAPK11))

Andere Bezeichnung: Mitogen Activated Protein Kinase 11 (MAPK11 Produkte)

Synonyme: ATMPK11 antikoerper, F22L4.10 antikoerper, F22L4_10 antikoerper, MAP kinase 11 antikoerper, zgc:86905 antikoerper, P38B antikoerper, P38BETA2 antikoerper, PRKM11 antikoerper, SAPK2 antikoerper, SAPK2B antikoerper, p38-2 antikoerper, p38Beta antikoerper, P38b antikoerper, Prkm11 antikoerper, Sapk2 antikoerper, Sapk2b antikoerper, p38beta antikoerper, p38beta2 antikoerper, p38b antikoerper, sapk2 antikoerper, prkm11 antikoerper, sapk2b antikoerper, mitogen-activated protein kinase 11 antikoerper, MAP kinase 11 antikoerper, mapk11 antikoerper, LOC9328118 antikoerper, MPK11 antikoerper, MAPK11 antikoerper, Mapk11 antikoerper, PTRG_02565 antikoerper

Pathways: MAPK Signalweg, Neurotrophin Signalübertragung, Activation of Innate immune Response, Response to Water Deprivation, Regulation of Muscle Cell Differentiation, ER-Nucleus Signaling, Hepatitis C, Toll-Like Receptors Cascades, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, BCR Signaling, S100 Proteine